Ignite Creation Date:
2024-05-06 @ 3:53 AM
Last Modification Date:
2024-10-26 @ 11:41 AM
Study NCT ID:
NCT02407509
Status:
RECRUITING
Last Update Posted:
2024-03-21
First Post:
2015-02-09
Brief Title:
Phase I Trial of VS-6766 Alone and in Combination With Everolimus
Sponsor:
Royal Marsden NHS Foundation Trust
Organization:
Royal Marsden NHS Foundation Trust
Organization Data
Organization:
Royal Marsden NHS Foundation Trust
Class:
OTHER
Study ID:
CCR3808
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Royal Marsden NHS Foundation Trust
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Verastem Inc | INDUSTRY |
| Institute of Cancer Research United Kingdom | OTHER |
| Chugai Pharmaceutical | INDUSTRY |